Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-50950
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Webile 1.0.1 Directory Traversal Vulnerability via Web Application
Source: NVD (National Vulnerability Database)
Vulnerability Description
Webile 1.0.1 contains a directory traversal vulnerability that allows remote attackers to manipulate file system paths without authentication. Attackers can exploit path manipulation to access sensitive system directories and potentially compromise the mobile device's local file system.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
对路径名的限制不恰当(路径遍历)
Source: NVD (National Vulnerability Database)
Vulnerability Title
webileapps Webile 路径遍历漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
webileapps Webile是webileapps公司的一个应用系统。 webileapps Webile 1.0.1版本存在路径遍历漏洞,该漏洞源于目录遍历漏洞,可能导致访问敏感系统目录。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Product Owner: WebileWebile 1.0.1 -
II. Public POCs for CVE-2022-50950
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-50950
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-50950

No comments yet


Leave a comment